12.11
Orthofix Medical Inc stock is traded at $12.11, with a volume of 568.61K.
It is down -1.62% in the last 24 hours and down -17.73% over the past month.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
See More
Previous Close:
$12.31
Open:
$12.5
24h Volume:
568.61K
Relative Volume:
2.21
Market Cap:
$540.30M
Revenue:
$771.65M
Net Income/Loss:
$-120.49M
P/E Ratio:
-3.7962
EPS:
-3.19
Net Cash Flow:
$-73.76M
1W Performance:
-12.18%
1M Performance:
-17.73%
6M Performance:
-37.61%
1Y Performance:
-16.43%
Orthofix Medical Inc Stock (OFIX) Company Profile
Name
Orthofix Medical Inc
Sector
Industry
Phone
214-937-2000
Address
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OFIX
Orthofix Medical Inc
|
12.11 | 540.30M | 771.65M | -120.49M | -73.76M | -3.19 |
![]()
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-22-25 | Initiated | Canaccord Genuity | Buy |
Nov-08-24 | Upgrade | Stifel | Hold → Buy |
May-08-24 | Upgrade | ROTH MKM | Neutral → Buy |
Oct-20-23 | Initiated | ROTH MKM | Neutral |
Sep-12-23 | Downgrade | BTIG Research | Buy → Neutral |
Sep-12-23 | Downgrade | Stifel | Buy → Hold |
Jul-19-23 | Resumed | BTIG Research | Buy |
Mar-04-22 | Upgrade | Stifel | Hold → Buy |
Oct-20-20 | Initiated | Stifel | Hold |
Oct-29-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
Jun-21-17 | Initiated | BTIG Research | Buy |
Jun-14-17 | Initiated | Ladenburg Thalmann | Buy |
May-23-17 | Initiated | SunTrust | Buy |
Jul-10-15 | Initiated | Sidoti | Buy |
May-09-13 | Downgrade | Mizuho | Buy → Neutral |
Jan-08-13 | Reiterated | Mizuho | Buy |
Jun-21-10 | Initiated | Boenning & Scattergood | Outperform |
Mar-09-10 | Reiterated | Jefferies & Co | Buy |
Feb-18-10 | Upgrade | Susquehanna Financial | Neutral → Positive |
Jan-22-10 | Initiated | Jefferies & Co | Buy |
Nov-03-09 | Upgrade | Wells Fargo | Underperform → Market Perform |
Jul-31-09 | Reiterated | Jefferies & Co | Buy |
Jul-31-09 | Upgrade | Thomas Weisel | Market Weight → Overweight |
May-26-09 | Reiterated | Jefferies & Co | Buy |
Apr-17-09 | Downgrade | Wachovia | Mkt Perform → Underperform |
Feb-19-09 | Initiated | Canaccord Adams | Buy |
Jul-07-08 | Downgrade | Wachovia | Outperform → Mkt Perform |
View All
Orthofix Medical Inc Stock (OFIX) Latest News
Bone Grafts and Substitutes Market to Reach $4.4 Billion by 2033, - openPR.com
Lost Money on Orthofix Medical Inc.(OFIX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Orthofix Medical Inc. (OFIX)October 21, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on Orthofix Medical Inc. (OFIX) should contact Levi & Korsinsky about pending Class ActionOFIX - ACCESS Newswire
Orthofix targets $808M to $816M revenue in 2025 with key product launches - MSN
Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Bone Regeneration Market Size, Share, Growth | 2025-2034 - Allied Market Research
Stifel maintains Buy on Orthofix stock, reiterates $24 target By Investing.com - Investing.com Australia
Institutional investors may adopt severe steps after Orthofix Medical Inc.'s (NASDAQ:OFIX) latest 15% drop adds to a year losses - simplywall.st
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2025 Earnings Call Transcript - Insider Monkey
Orthofix Q1 2025 net sales increase 3% to USD 193.6M - Medical Buyer
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Call Highlights: Strong Growth in Orthopedics and ... - Yahoo Finance
Orthofix Medical Reports Q1 2025 Financial Growth - TipRanks
Orthofix: Q1 Earnings Snapshot - Midland Daily News
Stifel maintains Buy on Orthofix stock, reiterates $24 target - Investing.com
Orthofix Medical Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:OFIX) - Seeking Alpha
Earnings call transcript: Orthofix Q1 2025 misses EPS forecasts, shares fall - Investing.com
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OFIX Exceeds Q1 Revenue Expectations Amid Business Transformatio - GuruFocus
Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA G - GuruFocus
Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA Guidance | OFIX Stock News - GuruFocus
Orthofix Reports First Quarter 2025 Financial Results - BioSpace
Orthofix Medical Inc (OFIX) Q1 Earnings: Revenue Surpasses Estimates at $193.6M, EPS Misses with $(1.35) Loss - GuruFocus
Orthofix Gains FDA Clearance for New Bone System - TipRanks
Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand - Investing.com Australia
Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand By Investing.com - Investing.com South Africa
Orthofix Medical Inc. SEC 10-Q Report - TradingView
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Orthofix Medical Inc. (OFIX) Shareholders - ACCESS Newswire
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Orthofix Medical CLO Sells Shares to Cover Tax Obligations - TradingView
Orthofix Medical Inc Stock (OFIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orthofix Medical Inc Stock (OFIX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Cedron Jorge Andres | CLO |
Apr 16 '25 |
Sale |
13.31 |
3,816 |
50,791 |
42,500 |
Gillespie Geoffrey C | CAO |
Apr 02 '25 |
Sale |
15.74 |
76 |
1,196 |
42,445 |
Vitale Lucas | CP&BOO |
Mar 18 '25 |
Sale |
16.60 |
4,287 |
71,164 |
135,317 |
Gillespie Geoffrey C | CAO |
Mar 18 '25 |
Sale |
16.60 |
296 |
4,914 |
42,521 |
Calafiore Massimo | President & CEO |
Mar 05 '25 |
Buy |
17.43 |
9,914 |
172,801 |
222,404 |
Gillespie Geoffrey C | CAO |
Feb 03 '25 |
Sale |
17.79 |
767 |
13,645 |
39,323 |
Gillespie Geoffrey C | CAO |
Feb 04 '25 |
Sale |
18.08 |
187 |
3,381 |
39,136 |
Andrews Julie | CFO |
Jan 16 '25 |
Sale |
17.89 |
4,655 |
83,278 |
28,312 |
Calafiore Massimo | President & CEO |
Jan 10 '25 |
Sale |
16.83 |
10,078 |
169,619 |
133,354 |
Calafiore Massimo | President & CEO |
Jan 13 '25 |
Sale |
17.14 |
9,203 |
157,757 |
124,151 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):